Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma-Acinar Adenocarcinoma of the Prostate by 68Ga-PSMA, 68Ga-FAPI, and 18F-FDG PET/CT

被引：4
|
作者：
Cai, Jiayu [1 ,2 ]
Xu, Weizhi [1 ,2 ]
Meng, Tinghua [1 ,2 ]
Pang, YiZhen [1 ,2 ]
Chen, Haojun [1 ,2 ,3 ]
机构：
[1] Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Ctr, Sch Med,Dept Nucl Med, Xiamen, Peoples R China
[2] Xiamen Univ, Affiliated Hosp 1, Minnan PET Ctr, Xiamen Canc Ctr,Sch Med, Xiamen, Peoples R China
[3] 55 Zhenhai Rd, Xiamen 361003, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2023年 / 48卷 / 08期
基金：
中国国家自然科学基金;
关键词：
F-18-FDG; Ga-68-FAPI; Ga-68-PSMA; neuroendocrine adenocarcinoma; neuroendocrine prostate cancer; PET/CT;
D O I：
10.1097/RLU.0000000000004719
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Mixed neuroendocrine carcinoma-acinar carcinoma is an uncommon histological type of neuroendocrine prostate cancer. It has been rarely reported in de novo prostate malignancies. In this case, we present Ga-68-PSMA (prostate-specific membrane antigen), Ga-68-FAPI, and F-18-FDG PET/CT findings in the de novo form of mixed large-cell neuroendocrine carcinoma-acinar adenocarcinoma of the prostate. Different levels of radiotracer uptake were observed in different metastatic sites on Ga-68-PSMA, Ga-68-FAPI, and F-18-FDG PET/CT. This case demonstrates that the multitracer PET/CT strategy may be used for the noninvasive detection of the intermetastatic heterogeneity in metastatic neuroendocrine prostate cancer.
引用
收藏
页码：743 / 745
页数：3
相关论文
共 50 条
  • [1] 68Ga-PSMA and 68Ga-FAPI-04 PET/CT Findings With 18F-FDG PET/CT in a Patient With Recurrent Prostate Cancer
    Tatar, Gamze
    Ergul, Nurhan
    Baloglu, Mehmet Can
    Arslan, Esra
    Cermik, Tevfik Fikret
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (03) : E135 - E137
  • [2] Comparison of 68Ga-FAPI and 18F-FDG PET/CT in Dermatofibrosarcoma Protuberans
    Wu, Junhao
    Zhang, Shumao
    Rao, Zijuan
    Wang, Yingwei
    Zhang, Chunyin
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (07) : 629 - 631
  • [3] 68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma
    Gundogan, Cihan
    Ergul, Nurhan
    Cakir, Mehmet Semih
    Kilickesmez, Ozgur
    Gursu, Riza Umar
    Aksoy, Tamer
    Cermik, Tevfik Fikret
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2021, 30 (02) : 79 - 85
  • [4] Comparison of 18F-FDG and 68Ga-FAPI PET/CT in Gastric Kaposi Sarcoma
    Tatar, Gamze
    Beyhan, Ediz
    Erol Fenercioglu, Ozge
    Arslan, Esra
    cermik, Tevfik Fikret
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (09) : E596 - E599
  • [5] 68Ga-FAPI and 18F-FDG PET/CT in Perineum Extramammary Paget Disease
    Jiang, Chunjuan
    Song, Shaoli
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : 342 - 344
  • [6] Primary Pulmonary MALT Lymphoma on 18F-FDG and 68Ga-FAPI PET/CT
    Wang, Rongxi
    Chen, Jingci
    Wang, Jiarou
    Zhu, Zhaohui
    Zhang, Jingjing
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (06) : e372 - e373
  • [7] Comparison of 18F-FDG PET/CT and 68Ga-FAPI in Spindle Cell Rhabdomyosarcoma
    Shen, Zhihui
    Wang, Ruimin
    DIAGNOSTICS, 2023, 13 (18)
  • [8] Comparison of 18F-FDG and 68Ga-FAPI PET/CT in a Rare Renal Leiomyoma
    Liu, Yanggang
    Zhang, Shumao
    Lan, Lianjun
    Chen, Yue
    Qiu, Lin
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (10) : 899 - 901
  • [9] Comparative Findings Between 68Ga-PSMA and 18F-FDG PET/CT for Hepatocellular Carcinoma
    Erhamamci, Seval
    Aslan, Nesrin
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2020, 29 (03) : 135 - 138
  • [10] Superiority of 18F-FDG PET/CT to 68GA-FAPI PET/CT in Adrenocortical Tumor Imaging
    Kaplan, Ihsan
    Can, Canan
    Kepenek, Ferat
    Ibiloglu, Ibrahim
    Guzel, Yunus
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (06) : E307 - E309
12345